Therefore, the therapeutic targeting of protein SUMOylation may represent a novel approach for the treatment of myriad cancers, including GBM; interestingly recent reports have also emerged demonstrating that elevations in the conjugation of NEDD8 are involved in the pathogenesis of GBM34. Here, NEDD8 is linked to glioblastoma.